How many capsules of diammonium glycyrrhizinate enteric-coated capsules should be taken?
Dec 03, 2025
Source: Cainiu Health
Dr. Huang Yuhong
Introduction
Diammonium Glycyrrhizinate Enteric-coated Capsules are available in 50 mg per capsule. A single dose of 150 mg (3 capsules), taken three times daily, can maintain a stable plasma drug concentration and is suitable for the treatment of acute and chronic hepatitis accompanied by elevated alanine aminotransferase levels. The active ingredient exerts anti-inflammatory and hepatoprotective effects by inhibiting the release of inflammatory factors and stabilizing the structure of hepatocyte membranes.
Generally, three capsules of diammonium glycyrrhizinate enteric-coated capsules are taken orally at a time, three times daily. If any abnormalities occur, prompt medical consultation is recommended. Detailed information is as follows:
Each capsule of diammonium glycyrrhizinate enteric-coated capsule contains 50 mg of the drug. A single dose of 150 mg (i.e., three capsules), taken three times daily, helps maintain a stable plasma concentration and is suitable for the treatment of acute or chronic hepatitis accompanied by elevated alanine aminotransferase (ALT) levels. The active ingredient exerts anti-inflammatory and hepatoprotective effects by inhibiting the release of inflammatory factors and stabilizing the structure of hepatocyte membranes.
The bioavailability of this medication is not affected by food intake, so it can be taken before or after meals. The duration of treatment should be adjusted based on the recovery of liver function—shorter courses are typically used for acute hepatitis, while chronic hepatitis often requires long-term maintenance therapy. Blood pressure, serum potassium, and serum sodium levels should be monitored regularly during treatment. Symptoms such as headache, edema, or muscle weakness may indicate electrolyte disturbances, in which case the drug should be discontinued immediately and medical attention sought.
Concurrent use of potassium-wasting diuretics or glucocorticoids should be avoided during treatment. The medication is contraindicated in pregnant women and patients with severe renal insufficiency.
